Paper423483
Influence of spironolactone on serum corticosteroids in primary hyperaldosteronism.
Abshagen U and 2 others. Klin Wochenschr, 1979. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Influence of spironolactone on serum corticosteroids in primary hyperaldosteronism. Papers, record 423483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/423483
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenal Cortex Hormones | Major topic |
| Hyperaldosteronism | Major topic |
| Spironolactone | Major topic |
| Adult | |
| Depression, Chemical | |
| Humans | |
| Male | |
| Middle Aged | |
| Potassium | |
| Sodium |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 927164 | Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies. | Metabolism | 1977 | https://conductscience.org/library/papers/927164 | PubMed |
| 2 | 1011842 | The effect of angiotensin II infusion on plasma corticosteroid concentrations in normal man. | J Steroid Biochem | 1976 | https://conductscience.org/library/papers/1011842 | PubMed |
| 3 | 211313 | Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication. | Klin Wochenschr | 1975 | https://conductscience.org/library/papers/211313 | PubMed |
| 4 | 4522169 | Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension. | Clin Sci Mol Med Suppl | 1973 | https://conductscience.org/library/papers/4522169 | PubMed |
| 5 | 4370321 | Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case. | J Clin Endocrinol Metab | 1974 | https://conductscience.org/library/papers/4370321 | PubMed |
| 6 | 971711 | Effect of aldosterone antagonist canrenone on plasma aldosterone concentration and plasma renin activity, and on the excretion of aldosterone and electrolytes by man. | Eur J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/971711 | PubMed |
| 7 | 642407 | Interference of spironolactone therapy with adrenal steroid metabolism in secondary hyperaldosteronism. | Klin Wochenschr | 1978 | https://conductscience.org/library/papers/642407 | PubMed |
| 8 | 5040820 | Radioimmunoassay of free aldosterone and of its 18-oxo-glucuronide in human urine. | Experientia | 1972 | https://conductscience.org/library/papers/5040820 | PubMed |
| 9 | 892704 | Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism. | Horm Res | 1977 | https://conductscience.org/library/papers/892704 | PubMed |
| 10 | 4370810 | Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man. | J Clin Endocrinol Metab | 1974 | https://conductscience.org/library/papers/4370810 | PubMed |
| 11 | 4342887 | The regulation of aldosterone secretion in primary aldosteronism. | Am J Med | 1972 | https://conductscience.org/library/papers/4342887 | PubMed |
| 12 | 5044814 | Fluorometric microassay for spironolactone and its metabolites in biological fluids. | J Pharm Sci | 1972 | https://conductscience.org/library/papers/5044814 | PubMed |
| 13 | 13957346 | Cytoplasmic bodies in the adrenal cortex of patients treated with spirolactone. | Lancet | 1963 | https://conductscience.org/library/papers/13957346 | PubMed |
| 14 | 4340533 | Stimulation of aldosterone production in vitro and its inhibition by spironolactone. | Naunyn Schmiedebergs Arch Pharmacol | 1972 | https://conductscience.org/library/papers/4340533 | PubMed |
| 15 | 4333501 | Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states. | Eur J Clin Invest | 1971 | https://conductscience.org/library/papers/4333501 | PubMed |
| 16 | 5913296 | Relation between potassium balance and aldosterone secretion in normal subjects and in patients with hypertensive or renal tubular disease. | J Clin Invest | 1966 | https://conductscience.org/library/papers/5913296 | PubMed |
| 17 | 874049 | Increased plasma 11-deoxycorticosterone during spironolactone medication. | J Clin Endocrinol Metab | 1977 | https://conductscience.org/library/papers/874049 | PubMed |
| 18 | 4356136 | Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. | J Clin Endocrinol Metab | 1973 | https://conductscience.org/library/papers/4356136 | PubMed |
| 19 | 4280522 | Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man. | Naunyn Schmiedebergs Arch Pharmacol | 1974 | https://conductscience.org/library/papers/4280522 | PubMed |
| 20 | 4267313 | On the mechanism of the inhibitory action of the spirolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitro. | Naunyn Schmiedebergs Arch Pharmacol | 1973 | https://conductscience.org/library/papers/4267313 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/423483
GET https://conductscience.org/api/papers/v1/423483/references?page=2